Elevance Health, formerly Anthem, is a US health insurer. The company runs plans under the Blue Cross Blue Shield brand in many states, for employers, Medicaid and Medicare, and offers health and pharmacy services through Carelon. As of Oct 13, 2026
As of Oct 13, 2026Fact sheet (from the annual report)Health insurance and health plans · Indianapolis, USAfull fact sheet
Elevance Health is a health insurer in the United States with managed care plans for individuals, employer groups and for Medicaid and Medicare. As an independent licensee of Blue Cross and Blue Shield, the company operates in California, Colorado, Georgia and Indiana, among other states. The Health Benefits segment offers full-risk health insurance as well as dental, vision and supplemental insurance. The CarelonRx segment provides pharmacy services such as mail-order and specialty pharmacies, claims processing and formularies for its own and external customers. In March 2024 the acquisition of Paragon Healthcare added outpatient infusion centers to CarelonRx.
Calculated automatically by fixed rules – not investment advice, check for yourself. How we analyze
Price performance at a glance
Last 30 trading days
Today−2.0%
7 days+0.3%
30 days+8.9%
1 year+26.0%
Day range (last trading day)
−0.3%Price at 12% of the range+2.5%
52-week range
−36.3%Price at 89% of the range+4.5%
Distance from the all-time high
−24.0%
Our own calculation from the exchange’s daily candles, as of Oct 26, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Load chart from TradingView
This transfers data (including your IP address) to TradingView, also to the USA. More in the Privacy policy.
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
Elevance Health · Sector Health Care · amounts in USD
Information only – does not affect our buy zones, not investment advice. Source: SEC filings, As of Feb 6, 2026.
In short
Light green: Revenue grew over 5 years (+10.3% per year), at least as fast as the sector median.
Light yellow: Net income (total) grew over 5 years (+4.4% per year), more slowly than the sector median; per share +7.0% per year.
Light yellow: Net margin 2.8%, below the sector median (12.9%).
Light yellow: Debt higher than usual in the sector.
Light green: Profit in each of the last 10 fiscal years.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in USD
050B100B150B200B
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Revenue 84.9B USD · Net income 2.5B USD · Net margin 2.9%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Revenue 90.0B USD · Net income 3.8B USD · Net margin 4.3%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Revenue 92.1B USD · Net income 3.8B USD · Net margin 4.1%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Revenue 104.2B USD · Net income 4.8B USD · Net margin 4.6%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Revenue 121.9B USD · Net income 4.6B USD · Net margin 3.8%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Revenue 138.6B USD · Net income 6.1B USD · Net margin 4.4%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Revenue 156.6B USD · Net income 6.0B USD · Net margin 3.8%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Revenue 171.3B USD · Net income 6.0B USD · Net margin 3.5%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Revenue 177.0B USD · Net income 6.0B USD · Net margin 3.4%
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 199.1B USD · Net income 5.7B USD · Net margin 2.8%
Margin
3%4%4%5%4%4%4%3%3%3%
RevenueNet incomeNet margin (below)in USD
020B40B60B
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Revenue 42.6B USD · Net income 856.0M USD · Net margin 2.0% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Revenue 42.6B USD · Net income 2.2B USD · Net margin 5.3%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Revenue 43.9B USD · Net income 2.3B USD · Net margin 5.2%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Revenue 45.1B USD · Net income 1.0B USD · Net margin 2.3%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Revenue 45.4B USD · Net income 418.0M USD · Net margin 0.9% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Revenue 48.9B USD · Net income 2.2B USD · Net margin 4.5%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Revenue 49.8B USD · Net income 1.7B USD · Net margin 3.5%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Revenue 50.7B USD · Net income 1.2B USD · Net margin 2.3%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Revenue 49.7B USD · Net income 547.0M USD · Net margin 1.1% · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Revenue 50.2B USD · Net income 1.8B USD · Net margin 3.5%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Revenue 50.5B USD · Net income 1.5B USD · Net margin 2.9%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Revenue 51.4B USD · Net income 1.4B USD · Net margin 2.7%
Margin
2%5%5%2%1%4%4%2%1%4%3%3%
Earnings per shareUSD per share
0102030
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Earnings per share 9.21 USD
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Earnings per share 14.35 USD
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Earnings per share 14.19 USD
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Earnings per share 18.47 USD
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Earnings per share 17.98 USD
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Earnings per share 24.73 USD
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Earnings per share 24.81 USD
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Earnings per share 25.22 USD
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Earnings per share 25.68 USD
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Earnings per share 25.21 USD
Earnings per shareUSD per share
02.505.007.5010
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Earnings per share not reported separately for Q4
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Earnings per share 9.59 USD
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Earnings per share 9.85 USD
Dividend per sharePayout ratio (below)USD per share
02.004.006.00
2016Fiscal year 2016 (Jan 1, 2016 – Dec 31, 2016): Dividend per share 2.60 USD · Payout ratio 28.2%
2017Fiscal year 2017 (Jan 1, 2017 – Dec 31, 2017): Dividend per share 2.70 USD · Payout ratio 18.8%
2018Fiscal year 2018 (Jan 1, 2018 – Dec 31, 2018): Dividend per share 3.00 USD · Payout ratio 21.1%
2019Fiscal year 2019 (Jan 1, 2019 – Dec 31, 2019): Dividend per share 3.20 USD · Payout ratio 17.3%
2020Fiscal year 2020 (Jan 1, 2020 – Dec 31, 2020): Dividend per share 3.80 USD · Payout ratio 21.1%
2021Fiscal year 2021 (Jan 1, 2021 – Dec 31, 2021): Dividend per share 4.52 USD · Payout ratio 18.3%
2022Fiscal year 2022 (Jan 1, 2022 – Dec 31, 2022): Dividend per share 5.12 USD · Payout ratio 20.6%
2023Fiscal year 2023 (Jan 1, 2023 – Dec 31, 2023): Dividend per share 5.92 USD · Payout ratio 23.5%
2024Fiscal year 2024 (Jan 1, 2024 – Dec 31, 2024): Dividend per share not available · Payout ratio not available
2025Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Dividend per share not available · Payout ratio not available
Ratio
28%19%21%17%21%18%21%23%
Dividend per sharePayout ratio (below)USD per share
00.501.001.502.00
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Dividend per share 1.48 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Dividend per share 1.63 USD · Payout ratio 17.0%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Dividend per share 1.63 USD · Payout ratio 16.5%
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Dividend per share 1.63 USD · Payout ratio 37.4%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Dividend per share 1.63 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Dividend per share 1.71 USD · Payout ratio 17.8%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Dividend per share 1.71 USD · Payout ratio 22.2%
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Dividend per share 1.71 USD · Payout ratio 32.1%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Dividend per share 1.71 USD · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q1/26Quarter Q1/26 (Jan 1, 2026 – Mar 31, 2026): Dividend per share 1.72 USD · Payout ratio 21.5%
Q2/26Quarter Q2/26 (Apr 1, 2026 – Jun 30, 2026): Dividend per share 1.72 USD · Payout ratio 25.6%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Dividend per share 1.72 USD · Payout ratio 27.4%
Ratio
17%17%37%18%22%32%22%26%27%
Fiscal year 2025 (Jan 1, 2025 – Dec 31, 2025): Revenue 199.1B USD · Net income 5.7B USD · Net margin 2.8%
Key figures with traffic lights
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 63 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light green: above sector
+10.3%per year, last 5 years
Sector Health Care: median +7.8% (60 symbols)
What does this mean? Revenue: over 5 years it grew by 10.3% per year on average – at least as fast as the median company in the sector (+7.8%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light yellow: below sector
+4.4%per year, last 5 years
Sector Health Care: median +7.5% (46 symbols)
per share: +7.0% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it grew by 4.4% per year on average, but more slowly than the median company in the sector (+7.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 USD in revenue, 2.84 USD remained as profit – less than the median company in the sector (12.9%). Five years ago the margin was 3.8%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light yellow: higher than sector
0.69latest balance sheet
Sector Health Care: median 0.66 (40 symbols)
What does this mean? For every 1 USD of equity there is 0.69 USD of financial debt – more than the median company in the sector (0.66). More debt amplifies good and bad years alike.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light gray: none found
–Dividend / earnings per share
Sector Health Care: median 28% (31 symbols)
What does this mean? The loaded SEC filings of the last two fiscal years contain no dividend per share. Either the company pays none, or it reports it under a different tag.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light green: profit every year
10 of 10fiscal years with a profit
What does this mean? In 10 of the last 10 fiscal years the bottom line showed a profit. There were no losses in this period.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
199.1B USD
Revenue vs. prior year
+12.5%
Net income (FY)
5.7B USD
Net income vs. prior year
−5.3%
EPS (FY)
25.21 USD
13F funds with a position
0 of 9
Funds vs. prior quarter
−2
Shares held vs. prior quarter
−100.0%
Fiscal year to Dec 31, 2025 · 10-K filed Feb 6, 2026 · Balance sheet Sep 30, 2026 (filed Oct 21, 2026) · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).13F: reporting date Jun 30, 2026, 9 tracked funds have filed (latest Aug 14, 2026), filed with up to 45 days of delay. Stock positions only; comparison with Mar 31, 2026 only across funds that filed for both quarters.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2025
Dec 31, 2025
199.1B
5.7B
2.8%
25.21
–
–
2024
Dec 31, 2024
177.0B
6.0B
3.4%
25.68
–
–
2023
Dec 31, 2023
171.3B
6.0B
3.5%
25.22
5.92
23%
2022
Dec 31, 2022
156.6B
6.0B
3.8%
24.81
5.12
21%
2021
Dec 31, 2021
138.6B
6.1B
4.4%
24.73
4.52
18%
2020
Dec 31, 2020
121.9B
4.6B
3.8%
17.98
3.80
21%
2019
Dec 31, 2019
104.2B
4.8B
4.6%
18.47
3.20
17%
2018
Dec 31, 2018
92.1B
3.8B
4.1%
14.19
3.00
21%
2017
Dec 31, 2017
90.0B
3.8B
4.3%
14.35
2.70
19%
2016
Dec 31, 2016
84.9B
2.5B
2.9%
9.21
2.60
28%
Quarters (amounts in USD, per share in USD)
Quarter
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
Q3/26
Sep 30, 2026
51.4B
1.4B
2.7%
6.27
1.72
27%
Q2/26
Jun 30, 2026
50.5B
1.5B
2.9%
6.71
1.72
26%
Q1/26
Mar 31, 2026
50.2B
1.8B
3.5%
8.00
1.72
22%
Q4/25*
Dec 31, 2025
49.7B
547.0M
1.1%
–
1.71
–
Q3/25
Sep 30, 2025
50.7B
1.2B
2.3%
5.32
1.71
32%
Q2/25
Jun 30, 2025
49.8B
1.7B
3.5%
7.72
1.71
22%
Q1/25
Mar 31, 2025
48.9B
2.2B
4.5%
9.61
1.71
18%
Q4/24*
Dec 31, 2024
45.4B
418.0M
0.9%
–
1.63
–
Q3/24
Sep 30, 2024
45.1B
1.0B
2.3%
4.36
1.63
37%
Q2/24
Jun 30, 2024
43.9B
2.3B
5.2%
9.85
1.63
17%
Q1/24
Mar 31, 2024
42.6B
2.2B
5.3%
9.59
1.63
17%
Q4/23*
Dec 31, 2023
42.6B
856.0M
2.0%
–
1.48
–
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Trend score +90
Price vs. EMA 50+15
Price vs. EMA 200+15
EMA 50 vs. EMA 200+20
ADX (trend strength)+15
Highs and lows+10
Relative strength+15
Volatility and trend strength
ADX 14 (trend strength)27.1
Rel. strength 60 d+12.8%
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.